The influence of corticosteroids on hemostasis in healthy subjects

Essentials Corticosteroids are associated with venous thromboembolism in patients with inflammatory diseases. Healthy subjects received 0.5 mg kg−1 of prednisolone or placebo for 10 days in a randomized study. von Willebrand factor, plasminogen activator type 1 and in vitro thrombin generation were...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of thrombosis and haemostasis Ročník 14; číslo 4; s. 716 - 723
Hlavní autori:	Majoor, C. J., Sneeboer, M. M. S., Kievit, A., Meijers, J. C. M., Poll, T., Lutter, R., Bel, E. H., Kamphuisen, P. W.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Elsevier Limited 01.04.2016
Predmet:	Administration, Oral Adrenal Cortex Hormones - adverse effects Adult Blood Coagulation - drug effects corticosteroids Double-Blind Method Female Fibrin Fibrinogen Degradation Products - chemistry fibrinolysis Fibrinolysis - drug effects Health risk assessment Healthy Volunteers hemostasis Hemostasis - drug effects Humans Inflammation - complications Inflammatory diseases Male Plasminogen Activator Inhibitor 1 - blood Prednisolone - adverse effects pulmonary embolism therapy Thrombin - chemistry Thromboembolism Venous Thromboembolism - chemically induced von Willebrand Factor - chemistry Young Adult fibrinolysis hemostasis corticosteroids pulmonary embolism therapy healthy volunteers
ISSN:	1538-7933, 1538-7836, 1538-7836
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Essentials Corticosteroids are associated with venous thromboembolism in patients with inflammatory diseases. Healthy subjects received 0.5 mg kg−1 of prednisolone or placebo for 10 days in a randomized study. von Willebrand factor, plasminogen activator type 1 and in vitro thrombin generation were enhanced. Corticosteroids may contribute to the thromboembolic risk in patients with inflammatory diseases. Summary Background Corticosteroids have been associated with an increased risk of venous thromboembolism in patients treated for inflammatory diseases. It is unclear whether the thrombotic risk is induced by the inflammation of the underlying inflammatory diseases or whether corticosteroids are prothrombotic as well. Considering the widespread use of corticosteroids in clinical practise, it is critical to know whether corticosteroids enhance coagulation. Objective To investigate whether a 10‐day prednisolone burst therapy activates hemostasis in healthy individuals. Methods Healthy subjects received either 0.5 mg kg−1 day−1 of oral prednisolone or placebo. Venous blood was collected at baseline, day 1 and day 10 and tested for thrombin‐antithrombin complexes (TATc), D‐dimer, plasmin‐alpha2‐antiplasmin complexes (PAPc), plasminogen‐activator inhibitor type‐1 (PAI‐1), von Willebrand factor (VWF) and thrombin generation (peak thrombin, velocity index and endogenous thrombin potential [ETP]). Results Fifteen subjects received prednisolone and 16 placebo (median age 29 vs. 22 years, female subjects 33% vs. 56%, respectively). Peak thrombin and velocity index were higher in the placebo group at baseline. After 10 days of treatment, peak thrombin, velocity index, PAI‐1 and VWF increased in the oral prednisolone group as compared with the placebo group (15.8 [SD 16.3] vs. −0.1 [SD 16.1], 41.2 [SD 41.3] vs. −2.3 [SD 42.7], 18.0 [IQR 8.0–37.0] vs. 0.5 [IQR −18.5–13.0], 4.0 [IQR −1.0–12.0] vs. 0.0 [IQR −2.5–1.5], respectively). No changes were observed for TATc, ETP, PAPc and D‐dimer. Conclusions Oral prednisolone induces a procoagulant state in healthy subjects, suggesting that corticosteroid treatment may increase the thromboembolic risk in patients with inflammatory diseases.
AbstractList	Essentials Corticosteroids are associated with venous thromboembolism in patients with inflammatory diseases. Healthy subjects received 0.5 mg kg−1 of prednisolone or placebo for 10 days in a randomized study. von Willebrand factor, plasminogen activator type 1 and in vitro thrombin generation were enhanced. Corticosteroids may contribute to the thromboembolic risk in patients with inflammatory diseases. Summary Background Corticosteroids have been associated with an increased risk of venous thromboembolism in patients treated for inflammatory diseases. It is unclear whether the thrombotic risk is induced by the inflammation of the underlying inflammatory diseases or whether corticosteroids are prothrombotic as well. Considering the widespread use of corticosteroids in clinical practise, it is critical to know whether corticosteroids enhance coagulation. Objective To investigate whether a 10‐day prednisolone burst therapy activates hemostasis in healthy individuals. Methods Healthy subjects received either 0.5 mg kg−1 day−1 of oral prednisolone or placebo. Venous blood was collected at baseline, day 1 and day 10 and tested for thrombin‐antithrombin complexes (TATc), D‐dimer, plasmin‐alpha2‐antiplasmin complexes (PAPc), plasminogen‐activator inhibitor type‐1 (PAI‐1), von Willebrand factor (VWF) and thrombin generation (peak thrombin, velocity index and endogenous thrombin potential [ETP]). Results Fifteen subjects received prednisolone and 16 placebo (median age 29 vs. 22 years, female subjects 33% vs. 56%, respectively). Peak thrombin and velocity index were higher in the placebo group at baseline. After 10 days of treatment, peak thrombin, velocity index, PAI‐1 and VWF increased in the oral prednisolone group as compared with the placebo group (15.8 [SD 16.3] vs. −0.1 [SD 16.1], 41.2 [SD 41.3] vs. −2.3 [SD 42.7], 18.0 [IQR 8.0–37.0] vs. 0.5 [IQR −18.5–13.0], 4.0 [IQR −1.0–12.0] vs. 0.0 [IQR −2.5–1.5], respectively). No changes were observed for TATc, ETP, PAPc and D‐dimer. Conclusions Oral prednisolone induces a procoagulant state in healthy subjects, suggesting that corticosteroid treatment may increase the thromboembolic risk in patients with inflammatory diseases. Essentials Corticosteroids are associated with venous thromboembolism in patients with inflammatory diseases. Healthy subjects received 0.5 mg kg-1 of prednisolone or placebo for 10 days in a randomized study. von Willebrand factor, plasminogen activator type 1 and in vitro thrombin generation were enhanced. Corticosteroids may contribute to the thromboembolic risk in patients with inflammatory diseases. Summary Background Corticosteroids have been associated with an increased risk of venous thromboembolism in patients treated for inflammatory diseases. It is unclear whether the thrombotic risk is induced by the inflammation of the underlying inflammatory diseases or whether corticosteroids are prothrombotic as well. Considering the widespread use of corticosteroids in clinical practise, it is critical to know whether corticosteroids enhance coagulation. Objective To investigate whether a 10-day prednisolone burst therapy activates hemostasis in healthy individuals. Methods Healthy subjects received either 0.5 mg kg-1 day-1 of oral prednisolone or placebo. Venous blood was collected at baseline, day 1 and day 10 and tested for thrombin-antithrombin complexes (TATc), D-dimer, plasmin-alpha2-antiplasmin complexes (PAPc), plasminogen-activator inhibitor type-1 (PAI-1), von Willebrand factor (VWF) and thrombin generation (peak thrombin, velocity index and endogenous thrombin potential [ETP]). Results Fifteen subjects received prednisolone and 16 placebo (median age 29 vs. 22 years, female subjects 33% vs. 56%, respectively). Peak thrombin and velocity index were higher in the placebo group at baseline. After 10 days of treatment, peak thrombin, velocity index, PAI-1 and VWF increased in the oral prednisolone group as compared with the placebo group (15.8 [SD 16.3] vs. -0.1 [SD 16.1], 41.2 [SD 41.3] vs. -2.3 [SD 42.7], 18.0 [IQR 8.0-37.0] vs. 0.5 [IQR -18.5-13.0], 4.0 [IQR -1.0-12.0] vs. 0.0 [IQR -2.5-1.5], respectively). No changes were observed for TATc, ETP, PAPc and D-dimer. Conclusions Oral prednisolone induces a procoagulant state in healthy subjects, suggesting that corticosteroid treatment may increase the thromboembolic risk in patients with inflammatory diseases. BACKGROUNDCorticosteroids have been associated with an increased risk of venous thromboembolism in patients treated for inflammatory diseases. It is unclear whether the thrombotic risk is induced by the inflammation of the underlying inflammatory diseases or whether corticosteroids are prothrombotic as well. Considering the widespread use of corticosteroids in clinical practise, it is critical to know whether corticosteroids enhance coagulation.OBJECTIVETo investigate whether a 10-day prednisolone burst therapy activates hemostasis in healthy individuals.METHODSHealthy subjects received either 0.5 mg kg(-1) day(-1) of oral prednisolone or placebo. Venous blood was collected at baseline, day 1 and day 10 and tested for thrombin-antithrombin complexes (TATc), D-dimer, plasmin-alpha2-antiplasmin complexes (PAPc), plasminogen-activator inhibitor type-1 (PAI-1), von Willebrand factor (VWF) and thrombin generation (peak thrombin, velocity index and endogenous thrombin potential [ETP]).RESULTSFifteen subjects received prednisolone and 16 placebo (median age 29 vs. 22 years, female subjects 33% vs. 56%, respectively). Peak thrombin and velocity index were higher in the placebo group at baseline. After 10 days of treatment, peak thrombin, velocity index, PAI-1 and VWF increased in the oral prednisolone group as compared with the placebo group (15.8 [SD 16.3] vs. -0.1 [SD 16.1], 41.2 [SD 41.3] vs. -2.3 [SD 42.7], 18.0 [IQR 8.0-37.0] vs. 0.5 [IQR -18.5-13.0], 4.0 [IQR -1.0-12.0] vs. 0.0 [IQR -2.5-1.5], respectively). No changes were observed for TATc, ETP, PAPc and D-dimer.CONCLUSIONSOral prednisolone induces a procoagulant state in healthy subjects, suggesting that corticosteroid treatment may increase the thromboembolic risk in patients with inflammatory diseases. Corticosteroids have been associated with an increased risk of venous thromboembolism in patients treated for inflammatory diseases. It is unclear whether the thrombotic risk is induced by the inflammation of the underlying inflammatory diseases or whether corticosteroids are prothrombotic as well. Considering the widespread use of corticosteroids in clinical practise, it is critical to know whether corticosteroids enhance coagulation. To investigate whether a 10-day prednisolone burst therapy activates hemostasis in healthy individuals. Healthy subjects received either 0.5 mg kg(-1) day(-1) of oral prednisolone or placebo. Venous blood was collected at baseline, day 1 and day 10 and tested for thrombin-antithrombin complexes (TATc), D-dimer, plasmin-alpha2-antiplasmin complexes (PAPc), plasminogen-activator inhibitor type-1 (PAI-1), von Willebrand factor (VWF) and thrombin generation (peak thrombin, velocity index and endogenous thrombin potential [ETP]). Fifteen subjects received prednisolone and 16 placebo (median age 29 vs. 22 years, female subjects 33% vs. 56%, respectively). Peak thrombin and velocity index were higher in the placebo group at baseline. After 10 days of treatment, peak thrombin, velocity index, PAI-1 and VWF increased in the oral prednisolone group as compared with the placebo group (15.8 [SD 16.3] vs. -0.1 [SD 16.1], 41.2 [SD 41.3] vs. -2.3 [SD 42.7], 18.0 [IQR 8.0-37.0] vs. 0.5 [IQR -18.5-13.0], 4.0 [IQR -1.0-12.0] vs. 0.0 [IQR -2.5-1.5], respectively). No changes were observed for TATc, ETP, PAPc and D-dimer. Oral prednisolone induces a procoagulant state in healthy subjects, suggesting that corticosteroid treatment may increase the thromboembolic risk in patients with inflammatory diseases.
Author	Kamphuisen, P. W. Sneeboer, M. M. S. Kievit, A. Lutter, R. Bel, E. H. Majoor, C. J. Meijers, J. C. M. Poll, T.
Author_xml	– sequence: 1 givenname: C. J. surname: Majoor fullname: Majoor, C. J. organization: Academic Medical Center – sequence: 2 givenname: M. M. S. surname: Sneeboer fullname: Sneeboer, M. M. S. organization: Academic Medical Center – sequence: 3 givenname: A. surname: Kievit fullname: Kievit, A. organization: Academic Medical Center – sequence: 4 givenname: J. C. M. orcidid: 0000-0002-4198-6780 surname: Meijers fullname: Meijers, J. C. M. organization: Sanquin Research – sequence: 5 givenname: T. surname: Poll fullname: Poll, T. organization: Academic Medical Center – sequence: 6 givenname: R. surname: Lutter fullname: Lutter, R. organization: Academic Medical Center – sequence: 7 givenname: E. H. surname: Bel fullname: Bel, E. H. organization: Academic Medical Center – sequence: 8 givenname: P. W. surname: Kamphuisen fullname: Kamphuisen, P. W. organization: University Medical Center Groningen
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/26791678$$D View this record in MEDLINE/PubMed
BookMark	eNp10EtLAzEQB_AgFfvQg19AFrzooW1ms9nHUYtPCl7qOWSzszRlu6lJFum3N_ZxKZrLZOA3w_Afkl5rWiTkGugEwpuu_HICLE75GRkAZ_k4y1naO_4Lxvpk6NyKUih4TC9IP06zAtIsH5DHxRIj3dZNh63CyNSRMtZrZZxHa3TlItNGS1yHXjrtAg2dbPxyG7muXKHy7pKc17JxeHWoI_L5_LSYvY7nHy9vs4f5WCU84WOZJ3VCZRkXUrI4BpQVYhpTlldZmUIFFBEoAAIvs3AcxEValolK8mBYTtmI3O33bqz56tB5sdZOYdPIFk3nBGQ55QCc8kBvT-jKdLYN1-0UpSmHJKibg-rKNVZiY_Va2q04phPAdA-UNc5ZrIXSXnptWm-lbgRQ8Zu_CPmLXf5h4v5k4rj0L3vY_q0b3P4PxfvidT_xA5jfki8
CitedBy_id	crossref_primary_10_1111_bjh_17804 crossref_primary_10_3390_metabo13101092 crossref_primary_10_1055_a_2238_4782 crossref_primary_10_3389_fimmu_2025_1599639 crossref_primary_10_1111_iej_13533 crossref_primary_10_3390_life14121699 crossref_primary_10_1007_s12185_020_02899_6 crossref_primary_10_1183_13993003_01014_2016 crossref_primary_10_1111_ans_18242 crossref_primary_10_3390_ijms21217818 crossref_primary_10_1177_00033197221126248 crossref_primary_10_1111_trf_14607 crossref_primary_10_1177_0300060520986291 crossref_primary_10_1007_s00408_018_0142_6 crossref_primary_10_1136_bmjopen_2023_072810 crossref_primary_10_1182_blood_2020006098 crossref_primary_10_1371_journal_pone_0255950 crossref_primary_10_3390_diagnostics15070941 crossref_primary_10_1111_jth_13504 crossref_primary_10_3390_biom14121506 crossref_primary_10_3389_fimmu_2022_901005 crossref_primary_10_18087_cardio_2020_6_n1226 crossref_primary_10_1002_acr_25087 crossref_primary_10_1002_pbc_30812 crossref_primary_10_1111_bjh_17388 crossref_primary_10_3390_biomedicines11072052 crossref_primary_10_3390_cells10020471 crossref_primary_10_1016_j_jtha_2024_08_024 crossref_primary_10_14814_phy2_14515 crossref_primary_10_3390_jcm9072115 crossref_primary_10_1210_endrev_bnad016 crossref_primary_10_1016_j_cgh_2024_10_031 crossref_primary_10_1186_s12872_025_04600_3 crossref_primary_10_1055_s_0040_1722270 crossref_primary_10_1002_bcp_70007 crossref_primary_10_1177_24741264221074799 crossref_primary_10_1007_s10067_021_05781_w crossref_primary_10_1186_s13256_024_04791_x crossref_primary_10_1016_j_rpth_2024_102499 crossref_primary_10_1016_j_critrevonc_2024_104347 crossref_primary_10_1111_jvim_17067 crossref_primary_10_3390_diagnostics14192112 crossref_primary_10_1055_s_0041_1725009 crossref_primary_10_1016_j_molmet_2021_101265 crossref_primary_10_1038_s41598_022_25580_w crossref_primary_10_1016_j_jpba_2025_116947 crossref_primary_10_1038_s41598_024_59385_w crossref_primary_10_1093_rheumatology_keaf430 crossref_primary_10_1155_2022_3144685 crossref_primary_10_1177_17562848221100626
Cites_doi	10.1001/jamainternmed.2013.122 10.1160/TH04-10-0652 10.1097/01.TP.0000058544.71993.E6 10.1160/TH08-08-0551 10.1016/j.thromres.2005.06.006 10.1016/j.jsbmb.2009.05.001 10.1016/S0140-6736(09)61963-2 10.1152/ajpendo.00654.2005 10.1111/j.1365-2141.2005.05753.x 10.1016/j.atherosclerosis.2008.03.024 10.1097/00007890-200005270-00026 10.1378/chest.12-1446 10.1161/01.ATV.19.6.1555 10.1007/BF03343697 10.1002/art.1780390217 10.1002/jor.22776 10.1183/09031936.00043313 10.1111/j.1538-7836.2010.04034.x 10.1183/09031936.00120909 10.1097/FJC.0b013e3180cab148 10.1210/jc.2002-021605 10.1006/cimm.1993.1263 10.1159/000081724 10.1152/japplphysiol.00991.2005 10.1378/chest.08-1516 10.1159/000071636 10.1097/CCM.0b013e3181c98d21 10.1183/09031936.00150312
ContentType	Journal Article
Copyright	2016 International Society on Thrombosis and Haemostasis 2016 International Society on Thrombosis and Haemostasis. Copyright © 2016 International Society on Thrombosis and Haemostasis
Copyright_xml	– notice: 2016 International Society on Thrombosis and Haemostasis – notice: 2016 International Society on Thrombosis and Haemostasis. – notice: Copyright © 2016 International Society on Thrombosis and Haemostasis
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7U8 7X8 C1K JXQ
DOI	10.1111/jth.13265
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) TOXLINE MEDLINE - Academic Environmental Sciences and Pollution Management Toxline
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts TOXLINE MEDLINE - Academic Environmental Sciences and Pollution Management
DatabaseTitleList	AIDS and Cancer Research Abstracts TOXLINE MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1538-7836
EndPage	723
ExternalDocumentID	4017966351 26791678 10_1111_jth_13265 JTH13265
Genre	article Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article
GrantInformation_xml	– fundername: Dutch Lung Foundation funderid: 3.2.11.021
GroupedDBID	--- 05W 1OC 24P 29L 2WC 31~ 33P 36B 3SF 4.4 52U 52V 53G 5GY 5VS 66C 8-0 8-1 A00 AAESR AAEVG AAHHS AALRI AAONW AASGY AAXRX AAXUO AAZKR ABCUV ABDBF ABJNI ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADVLN ADXAS ADZMN AEEZP AEIMD AENEX AEQDE AFBPY AFEBI AFGKR AFJKZ AFPWT AFZJQ AHMBA AIACR AITUG AIURR AIWBW AJAOE AJBDE AKRWK ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMRAJ AMYDB ATUGU AZBYB AZVAB BAWUL BHBCM BMXJE BOGZA BRXPI C45 CAG COF CS3 DCZOG DIK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EBS EJD EMB EMK ESX F5P FDB FIJ FUBAC G-S GODZA HZ~ IHE IPNFZ IX1 KBYEO LATKE LEEKS LH4 LITHE LOXES LUTES LW6 LYRES M41 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ O66 O9- OIG OK1 OVD P2P P2W P4E PQQKQ ROL SUPJJ SV3 TEORI TR2 W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WVDHM WYJ ZZTAW AAMMB AAYWO AAYXX ACVFH ADCNI AEFGJ AEUPX AFPUW AGXDD AIDQK AIDYY AIGII AKBMS AKYEP APXCP CITATION EFKBS CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7U8 7X8 C1K JXQ
ID	FETCH-LOGICAL-c4545-a84f40ab29aa3221eadee62038d7b61d10ee1011e15b71671296bb4c482033803
IEDL.DBID	WIN
ISICitedReferencesCount	56
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000374979000011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1538-7933 1538-7836
IngestDate	Mon Sep 29 04:37:58 EDT 2025 Tue Oct 07 06:41:30 EDT 2025 Thu Apr 03 07:09:38 EDT 2025 Tue Nov 18 21:57:47 EST 2025 Wed Oct 29 21:10:35 EDT 2025 Wed Jan 22 16:19:51 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	4
Keywords	fibrinolysis hemostasis corticosteroids pulmonary embolism therapy healthy volunteers
Language	English
License	2016 International Society on Thrombosis and Haemostasis.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4545-a84f40ab29aa3221eadee62038d7b61d10ee1011e15b71671296bb4c482033803
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3
ORCID	0000-0002-4198-6780
OpenAccessLink	https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jth.13265
PMID	26791678
PQID	1780006514
PQPubID	1086376
PageCount	8
ParticipantIDs	proquest_miscellaneous_1780511505 proquest_journals_1780006514 pubmed_primary_26791678 crossref_citationtrail_10_1111_jth_13265 crossref_primary_10_1111_jth_13265 wiley_primary_10_1111_jth_13265_JTH13265
PublicationCentury	2000
PublicationDate	April 2016 2016-04-00 2016-Apr 20160401
PublicationDateYYYYMMDD	2016-04-01
PublicationDate_xml	– month: 04 year: 2016 text: April 2016
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England – name: Oxford
PublicationTitle	Journal of thrombosis and haemostasis
PublicationTitleAlternate	J Thromb Haemost
PublicationYear	2016
Publisher	Elsevier Limited
Publisher_xml	– name: Elsevier Limited
References	2010; 38 1996; 39 2005; 131 2010; 35 2000; 69 1991; 54 2000; 23 2013; 42 2015; 33 2009; 135 2006; 291 2007; 50 2013; 143 2006; 118 2003; 75 2014; 43 2003; 33 2009; 116 2004; 71 1999; 19 2010; 375 2009; 101 1993; 152 2013; 173 2005; 94 2009; 202 2006; 100 2003; 88 2010; 8 Gunen (10.1111/jth.13265_bb0040) 2010; 35 Nieuwdorp (10.1111/jth.13265_bb0085) 2009; 202 van Zaane (10.1111/jth.13265_bb0115) 2010; 8 Darmon (10.1111/jth.13265_bb0125) 2006; 291 Dover (10.1111/jth.13265_bb0130) 2007; 50 Sartori (10.1111/jth.13265_bb0090) 2003; 75 Kerachian (10.1111/jth.13265_bb0145) 2009; 116 Jilma (10.1111/jth.13265_bb0110) 2005; 94 Sartori (10.1111/jth.13265_bb0150) 2000; 69 Stuijver (10.1111/jth.13265_bb0050) 2013; 143 Lehmann (10.1111/jth.13265_bb0100) 2006; 100 Matta (10.1111/jth.13265_bb0010) 2009; 101 Johannesdottir (10.1111/jth.13265_bb0055) 2013; 173 Brotman (10.1111/jth.13265_bb0060) 2006; 118 Kagawa (10.1111/jth.13265_bb0075) 1991; 54 Grainge (10.1111/jth.13265_bb0015) 2010; 375 Hamilton (10.1111/jth.13265_bb0140) 1993; 152 Rizkallah (10.1111/jth.13265_bb0025) 2009; 135 Chung (10.1111/jth.13265_bb0045) 2014; 43 Yamamoto (10.1111/jth.13265_bb0135) 2004; 71 Fatti (10.1111/jth.13265_bb0120) 2000; 23 Esmon (10.1111/jth.13265_bb0030) 2005; 131 Majoor (10.1111/jth.13265_bb0020) 2013; 42 Inoh (10.1111/jth.13265_bb0070) 1996; 39 Perry (10.1111/jth.13265_bb0105) 2003; 88 Levi (10.1111/jth.13265_bb0035) 2010; 38 Hemker (10.1111/jth.13265_bb0095) 2003; 33 van den Dorpel (10.1111/jth.13265_bb0080) 1999; 19 McLawhorn (10.1111/jth.13265_bb0065) 2015; 33
References_xml	– volume: 8 start-page: 2483 year: 2010 end-page: 93 article-title: Systematic review on the effect of glucocorticoid use on procoagulant, anticoagulant and fibrinolytic factors publication-title: J Thromb Haemost – volume: 375 start-page: 657 year: 2010 end-page: 63 article-title: Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study publication-title: Lancet – volume: 131 start-page: 417 year: 2005 end-page: 30 article-title: The interactions between inflammation and coagulation publication-title: Br J Haematol – volume: 39 start-page: 287 year: 1996 end-page: 91 article-title: Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis publication-title: Arthritis Rheum – volume: 42 start-page: 655 year: 2013 end-page: 61 article-title: Risk of deep‐vein thrombosis and pulmonary embolism in asthma publication-title: Eur Respir J – volume: 143 start-page: 1337 year: 2013 end-page: 42 article-title: Use of oral glucocorticoids and the risk of pulmonary embolism: a population‐based case–control study publication-title: Chest – volume: 54 start-page: 429 year: 1991 end-page: 39 article-title: Plasma coagulation and fibrinolysis parameters in patients with collagen diseases, and analysis of the multimeric structure of von Willebrand factor (vWF) publication-title: Int J Hematol – volume: 118 start-page: 247 year: 2006 end-page: 52 article-title: Effects of short‐term glucocorticoids on hemostatic factors in healthy volunteers publication-title: Thromb Res – volume: 202 start-page: 296 year: 2009 end-page: 303 article-title: Tumor necrosis factor‐alpha inhibition protects against endotoxin‐induced endothelial glycocalyx perturbation publication-title: Atherosclerosis – volume: 19 start-page: 1555 year: 1999 end-page: 8 article-title: Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients publication-title: Arterioscler Thromb Vasc Biol – volume: 50 start-page: 321 year: 2007 end-page: 6 article-title: Acute effects of glucocorticoids on endothelial fibrinolytic and vasodilator function in humans publication-title: J Cardiovasc Pharmacol – volume: 135 start-page: 786 year: 2009 end-page: 93 article-title: Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis publication-title: Chest – volume: 116 start-page: 127 year: 2009 end-page: 33 article-title: Effect of high‐dose dexamethasone on endothelial haemostatic gene expression and neutrophil adhesion publication-title: J Steroid Biochem Mol Biol – volume: 94 start-page: 797 year: 2005 end-page: 801 article-title: High dose dexamethasone increases circulating P‐selectin and von Willebrand factor levels in healthy men publication-title: Thromb Haemost – volume: 43 start-page: 801 year: 2014 end-page: 7 article-title: Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study publication-title: Eur Respir J – volume: 291 start-page: E995 year: 2006 end-page: 1002 article-title: Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity publication-title: Am J Physiol Endocrinol Metab – volume: 23 start-page: 145 year: 2000 end-page: 50 article-title: Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome publication-title: J Endocrinol Invest – volume: 101 start-page: 134 year: 2009 end-page: 8 article-title: Risk of venous thromboembolism with rheumatoid arthritis publication-title: Thromb Haemost – volume: 69 start-page: 2116 year: 2000 end-page: 21 article-title: Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients publication-title: Transplantation – volume: 71 start-page: 295 year: 2004 end-page: 301 article-title: Dexamethasone increased plasminogen activator inhibitor‐1 expression on human umbilical vein endothelial cells: an additive effect to tumor necrosis factor‐alpha publication-title: Pathobiology – volume: 100 start-page: 690 year: 2006 end-page: 4 article-title: Platelet count and function at high altitude and in high‐altitude pulmonary edema publication-title: J Appl Physiol – volume: 38 start-page: S26 year: 2010 end-page: 34 article-title: Inflammation and coagulation publication-title: Crit Care Med – volume: 33 start-page: 4 year: 2003 end-page: 15 article-title: Calibrated automated thrombin generation measurement in clotting plasma publication-title: Pathophysiol Haemost Thromb – volume: 75 start-page: 994 year: 2003 end-page: 8 article-title: Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid‐free immunosuppression therapy publication-title: Transplantation – volume: 88 start-page: 6008 year: 2003 end-page: 14 article-title: Glucocorticoids and insulin sensitivity: dissociation of insulin's metabolic and vascular actions publication-title: J Clin Endocrinol Metab – volume: 152 start-page: 7 year: 1993 end-page: 17 article-title: Regulation of plasminogen activator inhibitor‐1 levels in human monocytes publication-title: Cell Immunol – volume: 35 start-page: 1243 year: 2010 end-page: 8 article-title: Venous thromboemboli and exacerbations of COPD publication-title: Eur Respir J – volume: 33 start-page: 412 year: 2015 end-page: 6 article-title: Effects of steroids on thrombogenic markers in patients undergoing unilateral total knee arthroplasty: a prospective, double‐blind, randomized controlled trial publication-title: J Orthop Res – volume: 173 start-page: 743 year: 2013 end-page: 52 article-title: Use of glucocorticoids and risk of venous thromboembolism: a nationwide population‐based case–control study publication-title: JAMA Intern Med – volume: 173 start-page: 743 year: 2013 ident: 10.1111/jth.13265_bb0055 article-title: Use of glucocorticoids and risk of venous thromboembolism: a nationwide population‐based case–control study publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2013.122 – volume: 94 start-page: 797 year: 2005 ident: 10.1111/jth.13265_bb0110 article-title: High dose dexamethasone increases circulating P‐selectin and von Willebrand factor levels in healthy men publication-title: Thromb Haemost doi: 10.1160/TH04-10-0652 – volume: 75 start-page: 994 year: 2003 ident: 10.1111/jth.13265_bb0090 article-title: Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid‐free immunosuppression therapy publication-title: Transplantation doi: 10.1097/01.TP.0000058544.71993.E6 – volume: 101 start-page: 134 year: 2009 ident: 10.1111/jth.13265_bb0010 article-title: Risk of venous thromboembolism with rheumatoid arthritis publication-title: Thromb Haemost doi: 10.1160/TH08-08-0551 – volume: 118 start-page: 247 year: 2006 ident: 10.1111/jth.13265_bb0060 article-title: Effects of short‐term glucocorticoids on hemostatic factors in healthy volunteers publication-title: Thromb Res doi: 10.1016/j.thromres.2005.06.006 – volume: 116 start-page: 127 year: 2009 ident: 10.1111/jth.13265_bb0145 article-title: Effect of high‐dose dexamethasone on endothelial haemostatic gene expression and neutrophil adhesion publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2009.05.001 – volume: 375 start-page: 657 year: 2010 ident: 10.1111/jth.13265_bb0015 article-title: Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study publication-title: Lancet doi: 10.1016/S0140-6736(09)61963-2 – volume: 291 start-page: E995 year: 2006 ident: 10.1111/jth.13265_bb0125 article-title: Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00654.2005 – volume: 131 start-page: 417 year: 2005 ident: 10.1111/jth.13265_bb0030 article-title: The interactions between inflammation and coagulation publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2005.05753.x – volume: 202 start-page: 296 year: 2009 ident: 10.1111/jth.13265_bb0085 article-title: Tumor necrosis factor‐alpha inhibition protects against endotoxin‐induced endothelial glycocalyx perturbation publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2008.03.024 – volume: 69 start-page: 2116 year: 2000 ident: 10.1111/jth.13265_bb0150 article-title: Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients publication-title: Transplantation doi: 10.1097/00007890-200005270-00026 – volume: 143 start-page: 1337 year: 2013 ident: 10.1111/jth.13265_bb0050 article-title: Use of oral glucocorticoids and the risk of pulmonary embolism: a population‐based case–control study publication-title: Chest doi: 10.1378/chest.12-1446 – volume: 19 start-page: 1555 year: 1999 ident: 10.1111/jth.13265_bb0080 article-title: Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.19.6.1555 – volume: 23 start-page: 145 year: 2000 ident: 10.1111/jth.13265_bb0120 article-title: Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome publication-title: J Endocrinol Invest doi: 10.1007/BF03343697 – volume: 39 start-page: 287 year: 1996 ident: 10.1111/jth.13265_bb0070 article-title: Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis publication-title: Arthritis Rheum doi: 10.1002/art.1780390217 – volume: 33 start-page: 412 year: 2015 ident: 10.1111/jth.13265_bb0065 article-title: Effects of steroids on thrombogenic markers in patients undergoing unilateral total knee arthroplasty: a prospective, double‐blind, randomized controlled trial publication-title: J Orthop Res doi: 10.1002/jor.22776 – volume: 43 start-page: 801 year: 2014 ident: 10.1111/jth.13265_bb0045 article-title: Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study publication-title: Eur Respir J doi: 10.1183/09031936.00043313 – volume: 8 start-page: 2483 year: 2010 ident: 10.1111/jth.13265_bb0115 article-title: Systematic review on the effect of glucocorticoid use on procoagulant, anticoagulant and fibrinolytic factors publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2010.04034.x – volume: 35 start-page: 1243 year: 2010 ident: 10.1111/jth.13265_bb0040 article-title: Venous thromboemboli and exacerbations of COPD publication-title: Eur Respir J doi: 10.1183/09031936.00120909 – volume: 50 start-page: 321 year: 2007 ident: 10.1111/jth.13265_bb0130 article-title: Acute effects of glucocorticoids on endothelial fibrinolytic and vasodilator function in humans publication-title: J Cardiovasc Pharmacol doi: 10.1097/FJC.0b013e3180cab148 – volume: 88 start-page: 6008 year: 2003 ident: 10.1111/jth.13265_bb0105 article-title: Glucocorticoids and insulin sensitivity: dissociation of insulin's metabolic and vascular actions publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2002-021605 – volume: 152 start-page: 7 year: 1993 ident: 10.1111/jth.13265_bb0140 article-title: Regulation of plasminogen activator inhibitor‐1 levels in human monocytes publication-title: Cell Immunol doi: 10.1006/cimm.1993.1263 – volume: 71 start-page: 295 year: 2004 ident: 10.1111/jth.13265_bb0135 article-title: Dexamethasone increased plasminogen activator inhibitor‐1 expression on human umbilical vein endothelial cells: an additive effect to tumor necrosis factor‐alpha publication-title: Pathobiology doi: 10.1159/000081724 – volume: 100 start-page: 690 year: 2006 ident: 10.1111/jth.13265_bb0100 article-title: Platelet count and function at high altitude and in high‐altitude pulmonary edema publication-title: J Appl Physiol doi: 10.1152/japplphysiol.00991.2005 – volume: 135 start-page: 786 year: 2009 ident: 10.1111/jth.13265_bb0025 article-title: Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis publication-title: Chest doi: 10.1378/chest.08-1516 – volume: 33 start-page: 4 year: 2003 ident: 10.1111/jth.13265_bb0095 article-title: Calibrated automated thrombin generation measurement in clotting plasma publication-title: Pathophysiol Haemost Thromb doi: 10.1159/000071636 – volume: 38 start-page: S26 year: 2010 ident: 10.1111/jth.13265_bb0035 article-title: Inflammation and coagulation publication-title: Crit Care Med doi: 10.1097/CCM.0b013e3181c98d21 – volume: 42 start-page: 655 year: 2013 ident: 10.1111/jth.13265_bb0020 article-title: Risk of deep‐vein thrombosis and pulmonary embolism in asthma publication-title: Eur Respir J doi: 10.1183/09031936.00150312 – volume: 54 start-page: 429 year: 1991 ident: 10.1111/jth.13265_bb0075 article-title: Plasma coagulation and fibrinolysis parameters in patients with collagen diseases, and analysis of the multimeric structure of von Willebrand factor (vWF) publication-title: Int J Hematol
SSID	ssj0019520
Score	2.427672
Snippet	Essentials Corticosteroids are associated with venous thromboembolism in patients with inflammatory diseases. Healthy subjects received 0.5 mg kg−1 of... Corticosteroids have been associated with an increased risk of venous thromboembolism in patients treated for inflammatory diseases. It is unclear whether the... Essentials Corticosteroids are associated with venous thromboembolism in patients with inflammatory diseases. Healthy subjects received 0.5 mg kg-1 of... BACKGROUNDCorticosteroids have been associated with an increased risk of venous thromboembolism in patients treated for inflammatory diseases. It is unclear...
SourceID	proquest pubmed crossref wiley
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	716
SubjectTerms	Administration, Oral Adrenal Cortex Hormones - adverse effects Adult Blood Coagulation - drug effects corticosteroids Double-Blind Method Female Fibrin Fibrinogen Degradation Products - chemistry fibrinolysis Fibrinolysis - drug effects Health risk assessment Healthy Volunteers hemostasis Hemostasis - drug effects Humans Inflammation - complications Inflammatory diseases Male Plasminogen Activator Inhibitor 1 - blood Prednisolone - adverse effects pulmonary embolism therapy Thrombin - chemistry Thromboembolism Venous Thromboembolism - chemically induced von Willebrand Factor - chemistry Young Adult
Title	The influence of corticosteroids on hemostasis in healthy subjects
URI	https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjth.13265 https://www.ncbi.nlm.nih.gov/pubmed/26791678 https://www.proquest.com/docview/1780006514 https://www.proquest.com/docview/1780511505
Volume	14
WOSCitedRecordID	wos000374979000011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1538-7836 dateEnd: 20221231 omitProxy: false ssIdentifier: ssj0019520 issn: 1538-7933 databaseCode: WIN dateStart: 20030101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1538-7836 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0019520 issn: 1538-7933 databaseCode: DRFUL dateStart: 20030101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZS8QwEB68EF-8j_VYovjgS6Vp06aLT16Lii4iu7pvJWlTdkFb2e4K_nsn6YGiguBbS6dNSOZrvslkZgAOPVdI6ca2ZbsR1waKtAQCy2Kx9sLYTCkTx_14yzudoN9v3U_BSRULU-SHqDfcNDLM_1oDXMj8M8jHg2M0pXwdYE4Z1dULnq47tQeh5ZmUjAbQqINumVXInOKp3vy6Fn0jmF_5qllw2kv_6uoyLJY8k5wWirECUypdhfm70pO-BmeoH2RYVSghWULQDEVZHfMxyoZxTrKUDNQL3ot8mKMoKUIm30k-kXrzJl-HXvuye35llfUUrIghUbJEwBJmC-m0hEAcU31WWvmO7QYxlz6Nqa0UIpQq6kk0ozhSAV9KFjFkCWjJ2u4GzKRZqraA-EgMuHCYH7iS8YS1pC1dSVmikAF4idOAo2pkw6hMNq5rXjyHtdExHoRmTBpwUIu-Fhk2fhLaraYnLEGWh5QHhkJR1oD9-jHCQ_s8RKqySSHjadaLn9gsprVuxfE5kmMeYGfN7P3efHjTvTIX238X3YEFJFd-ccpnF2bGo4nag7nobTzMR02Y5v2gCbMXD-3ebdOo7geYc-t4
linkProvider	Wiley-Blackwell
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB50FfXi-7E-o3jwUukjbbrgRUVZdXfxsD5uJWlTtqCtbHcF_72T9IGLCoK3lk6bkMzXfJPJzAAcuw4XwolMw3RCpgwUYXAElkEj5YUxqZQ6jvuxw3o9__m5dT8FZ1UsTJEfot5wU8jQ_2sFcLUh_RXlo8Ep2lKeOw0zFImGKtzwdNOrfQgtVydl1JBGLXTKvEL6HE_16uRq9I1iTjJWveRcL_2vs8uwWFJNcl7oxgpMyXQV5rqlM30NLlBFSFIVKSFZTNASRVkV9jHMkignWUoG8hXveZ7kKEqKqMkPko-F2r_J1-Hh-qp_2TbKkgpGSJErGdynMTW5sFucI5QtdVxaerbp-BETnhVZppQIUktarkBLiiEb8ISgIUWigMas6WxAI81SuQXEQ27AuE093xGUxbQlTOEIi8YSSYAb2004qYY2CMt846rsxUtQ2x2jQaDHpAlHtehbkWTjJ6Hdan6CEmd5YDFfsyiLNuGwfowIUW4PnspsXMi4ivjiJzaLea1bsT2G_Jj52Fk9fb83H9z22_pi---iBzDf7nc7Qeemd7cDC8i1vCKMcRcao-FY7sFs-D5K8uG-1txPaSrtDA
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZS8NAEB5qFfHF-6jnKj74Esmxyabgi1epWkuRKr6F3WRDC5qUphX8985uDhQVBN8SMskuu_Nlv9nZmQE4dh0uhBOZhumETBkowuAILINGygtjUil1HPdTh3W7_vNzs1eDszIWJs8PUW24KWTo_7UCuBxF8WeUTwanaEt57gzMUlVEpg6zVw-tx07lRWi6Oi2jBjXqoVNkFtInecqXv65H30jmV86qF53W0v-6uwyLBdkk57l2rEBNJqswf1-409fgApWEDMsyJSSNCdqiKKsCP8bpMMpImpCBfMV7ng0zFCV53OQ7yaZC7eBk6_DYuu5fto2iqIIRUmRLBvdpTE0u7CbnCGZLHZiWnm06fsSEZ0WWKSXC1JKWK9CWYsgHPCFoSJEqoDlrOhtQT9JEbgHxkB0wblPPdwRlMW0KUzjCorFEGuDGdgNOyqENwiLjuCp88RJUlsdkEOgxacBRJTrK02z8JLRbzk9QIC0LLOZrHmXRBhxWjxEjyvHBE5lOcxlXUV_8xGY-r1UrtseQITMfO6un7_fmg9t-W19s_130AOZ7V62gc9O924EFJFtefupnF-qT8VTuwVz4Nhlm4_1CdT8A21Pttw
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+influence+of+corticosteroids+on+hemostasis+in+healthy+subjects&rft.jtitle=Journal+of+thrombosis+and+haemostasis&rft.au=Majoor%2C+C+J&rft.au=Sneeboer%2C+M+M+S&rft.au=de+Kievit%2C+A&rft.au=Meijers%2C+J+C+M&rft.date=2016-04-01&rft.eissn=1538-7836&rft.volume=14&rft.issue=4&rft.spage=716&rft_id=info:doi/10.1111%2Fjth.13265&rft_id=info%3Apmid%2F26791678&rft.externalDocID=26791678
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-7933&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-7933&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-7933&client=summon